Singular Genomics Systems, Inc. (OMIC)
USD 19.6
(-0.56%)
USD 19.6
(-0.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.91 Million USD | 280.52% |
| 2022 | 765 Thousand USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 737 Thousand USD | 66.74% |
| 2024 Q1 | 442 Thousand USD | -59.11% |
| 2023 Q3 | 462 Thousand USD | -8.51% |
| 2023 FY | 2.91 Million USD | 280.52% |
| 2023 Q4 | 1.08 Million USD | 133.98% |
| 2023 Q2 | 505 Thousand USD | -41.48% |
| 2023 Q1 | 863 Thousand USD | 12.81% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 FY | 765 Thousand USD | 0.0% |
| 2022 Q4 | 765 Thousand USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | 96.988% |
| AngioDynamics, Inc. | 303.91 Million USD | 99.042% |
| AtriCure, Inc. | 399.24 Million USD | 99.271% |
| Avinger, Inc. | 7.65 Million USD | 61.958% |
| Azenta, Inc. | 665.07 Million USD | 99.562% |
| BioLife Solutions, Inc. | 143.27 Million USD | 97.968% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 99.919% |
| Daxor Corporation | 1.28 Million USD | -127.33% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | 84.075% |
| Femasys Inc. | 1.07 Million USD | -171.556% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 97.407% |
| Hologic, Inc. | 4.03 Billion USD | 99.928% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.871% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 99.959% |
| KORU Medical Systems, Inc. | 28.51 Million USD | 89.792% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 98.495% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -152.586% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -152.586% |
| Masimo Corporation | 2.04 Billion USD | 99.858% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 97.002% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 99.768% |
| Nephros, Inc. | 14.23 Million USD | 79.555% |
| NovoCure Limited | 509.33 Million USD | 99.428% |
| NEXGEL, Inc. | 4.08 Million USD | 28.809% |
| NEXGEL, Inc. | 4.08 Million USD | 28.809% |
| OraSure Technologies, Inc. | 405.47 Million USD | 99.282% |
| Pro-Dex, Inc. | 53.84 Million USD | 94.594% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -63.531% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | 84.763% |
| QuidelOrtho Corporation | 2.99 Billion USD | 99.903% |
| Repligen Corporation | 638.76 Million USD | 99.544% |
| Sanara MedTech Inc. | 64.98 Million USD | 95.521% |
| STAAR Surgical Company | 322.41 Million USD | 99.097% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | 94.204% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 99.927% |
| Jin Medical International Ltd. | 19.82 Million USD | 85.314% |